NTK BioPharma was founded by a Harvard graduate with skills in data analytics and a veteran of the biopharmaceutical industry with decades of experience in drug development, safety and risk management, and regulatory strategy—including a distinguished tenure at several major pharmaceutical companies. With a career dedicated to advancing healthcare through scientific rigor and translational insights, NTK BioPharma aspires to help biotech and pharmaceutical companies navigate the complexities of nonclinical safety and regulatory science.

This consulting practice is grounded in extensive industry knowledge, a commitment to scientific integrity, and a track record of delivering impactful safety assessments that enhance the success of drug discovery and development. We specialize in the nonclinical evaluation of compounds, risk assessment strategies, data mining, application of artificial intelligence tools to obtain greater insights and regulatory submissions across the R&D pipeline.

At NTK BioPharma, we partner with clients to provide expert-driven, data-informed solutions that improve decision-making, reduce development risks, and support the safe and efficient advancement of novel therapeutics.